Zoetis Inc (NYSE:ZTS)

49.77
Delayed Data
As of May 29
 +0.66 / +1.34%
Today’s Change
30.50
Today|||52-Week Range
49.96
+15.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$24.6B

Company Description

Zoetis, Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company manages its operations in four geographic regional segments: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific. Within each of these regions, it offers a diversified product portfolio, including vaccines, parasiticides, anti-infectives, medicated feed additives and other pharmaceuticals, for both livestock and companion animal customers. The company's origin dates back to Jan 1, 1952, when it was established as a division of Pfizer, Inc. Zoetis was founded in July 2012 and is headquartered in New York, NY.

Contact Information

Zoetis, Inc.
100 Campus Drive
Florham Park New Jersey 07932
P:(973) 822-7000
Investor Relations:

Employees

Shareholders

Other institutional54.87%
Mutual fund holders39.00%
Individual stakeholders17.22%

Top Executives

Juan Ramón AlaixPresident, Chief Executive Officer & Director
Paul S. HerendeenChief Financial Officer & Executive Vice President
Catherine Ann KnuppExecutive VP, President-Research & Development
Alejandro BernalExecutive Vice President & President-EMEA Region
Clinton A. LewisExecutive VP & President-International Operations

To view my watchlist

Not a member yet?

Sign up now for a free account